119 related articles for article (PubMed ID: 9730462)
1. Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays.
Leewansangtong S; Goktas S; Lepoff R; Holthaus K; Crawford ED
Urology; 1998 Sep; 52(3):467-9. PubMed ID: 9730462
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
Manseck A; Pilarsky C; Froschermaier S; Menschikowski M; Wirth MP
Urol Int; 1998; 60(1):25-7. PubMed ID: 9519417
[TBL] [Abstract][Full Text] [Related]
3. The variation of percent free prostate-specific antigen determined by two different assays.
Yang CR; Ou YC; Horng YY; Lee HS
Anticancer Res; 2003; 23(1B):707-11. PubMed ID: 12680171
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.
Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH
Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696
[TBL] [Abstract][Full Text] [Related]
5. Some analytical considerations on the measurement of prostate-specific antigen.
Blijenberg BG; Kranse R; Eman I; Schröder FH
Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):817-21. PubMed ID: 8933105
[TBL] [Abstract][Full Text] [Related]
6. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of assays for prostate-specific antigen molecular forms.
Kuriyama M; Uno H; Ueno K; Hamamoto Y; Vihn PQ; Ban Y
Jpn J Clin Oncol; 1999 Jun; 29(6):303-7. PubMed ID: 10418560
[TBL] [Abstract][Full Text] [Related]
8. Assay variability in serum prostate-specific antigen determination.
Brawer MK; Daum P; Petteway JC; Wener MH
Prostate; 1995 Jul; 27(1):1-6. PubMed ID: 7541527
[TBL] [Abstract][Full Text] [Related]
9. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
Vashi AR; Wojno KJ; Henricks W; England BA; Vessella RL; Lange PH; Wright GL; Schellhammer PF; Weigand RA; Olson RM; Dowell BL; Borden KK; Oesterling JE
Urology; 1997 Jan; 49(1):19-27. PubMed ID: 9000179
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of a new chemiluminescent assay for prostate specific antigen.
Dasgupta A; Wells A; Datta P
J Clin Lab Anal; 2000; 14(4):164-8. PubMed ID: 10906769
[TBL] [Abstract][Full Text] [Related]
11. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays.
Zhou AM; Tewari PC; Bluestein BI; Caldwell GW; Larsen FL
Clin Chem; 1993 Dec; 39(12):2483-91. PubMed ID: 7504592
[TBL] [Abstract][Full Text] [Related]
12. Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist.
Hofer C; Sauerstein P; Wolter C; Scholz M; Hartung R; Breul J
Urol Int; 2000; 64(1):18-23. PubMed ID: 10782027
[TBL] [Abstract][Full Text] [Related]
13. Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer.
Blijenberg BG; Bangma CH; Kranse R; Eman I; Schröder FH
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):111-4. PubMed ID: 9056753
[TBL] [Abstract][Full Text] [Related]
14. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx.
Oesterling JE; Moyad MA; Wright GL; Beck GR
Urology; 1995 Oct; 46(4):524-32. PubMed ID: 7571222
[TBL] [Abstract][Full Text] [Related]
15. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
[TBL] [Abstract][Full Text] [Related]
16. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of Tandem-R PSA and Markit-M PA in the diagnosis of prostate cancer].
Okegawa T; Kato M; Miyata A; Murata A; Miura I; Yoneda T; Nutahara K; Higashihara E
Hinyokika Kiyo; 1999 Mar; 45(3):175-8. PubMed ID: 10331169
[TBL] [Abstract][Full Text] [Related]
18. Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen.
Semjonow A; Oberpenning F; Brandt B; Zechel C; Brandau W; Hertle L
Urology; 1996 Dec; 48(6A Suppl):10-5. PubMed ID: 8973694
[TBL] [Abstract][Full Text] [Related]
19. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges.
Meshref AW; Bazinet M; Trudel C; Aronson S; Peloquin F; Nachabe M; Dessureault J; Aprikian AG; Begin LR; Elhilali MM
Urology; 1995 Jun; 45(6):972-9. PubMed ID: 7539562
[TBL] [Abstract][Full Text] [Related]
20. Different prostate-specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies.
Stephan C; Kramer J; Meyer HA; Kristiansen G; Ziemer S; Deger S; Lein M; Loening SA; Jung K
BJU Int; 2007 Jun; 99(6):1427-31. PubMed ID: 17355366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
